div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 4button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page4jpg target=_blank amp-img class=ts-thumb alt=Page 4: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 5button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page5jpg target=_blank amp-img class=ts-thumb alt=Page 5: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails5jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 6button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page6jpg target=_blank amp-img class=ts-thumb alt=Page 6: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails6jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 7button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page7jpg target=_blank amp-img class=ts-thumb alt=Page 7: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails7jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 8button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page8jpg target=_blank amp-img class=ts-thumb alt=Page 8: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails8jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 9button div class=ts-image a href=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5page9jpg target=_blank amp-img class=ts-thumb alt=Page 9: · TEKKA AKT¼BHA sonECT HA CROHN VI ynUEP03EH KOJIVIT C AHTVIUhTOKhHOBV1 nEKAPCTBEHV1 nPOAYKTV1 nph sonHV1 non 18 rOAhUJHA Bb3PACT Adalimumab Infliximab np0T0Kor1bT ce v13Aaaa src=https:reader043vdocumentspubreader043viewer20220315165d03711488c993c8248b489bhtml5thumbnails9jpg width=142 height=106 layout=responsive amp-imga divdiv